A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy

Post author:
Post published:October 11, 2023
Post category:uncategorized

The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

New rice discovery could be good news diabetics and rice lovers

Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Helpful Links

Subscribe To Us